Five Star Equities Issues New Research Reports on AMBI, MDCO, OCLS and WAG


Follow this company

Companies Mentioned

NASDAQ:AMBI / NASDAQ:MDCO / NASDAQ:OCLS / NYSE:WAG
12/05/2013 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Ambit Biosciences Corp. (NASDAQ: AMBI) shares dropped 33.12 percent to close at $8.56 a share Wednesday. The stock traded between $8.04 and $9.52 on volume 1.55 million shares traded. The company announced that it does not plan to submit a New Drug Application for accelerated approval of quizartinib. Shares of Ambit Biosciences have gained approximately 15.0 percent year-to-date.

Get more information on Ambit Biosciences free access to the in-depth equity report at:  
www.FiveStarEquities.com/AMBI

The Medicines Company (NASDAQ: MDCO) shares gained 3.15 percent to close at $37.70 a share Wednesday. The stock traded between $36.50 and $38.50 on volume 1.28 million shares traded. The company announced that it has acquired Rempex Pharmaceuticals, Inc. Shares of The Medicines Company have gained approximately 57.0 percent year-to-date.

Get more information on The Medicines Company and free access to the in-depth equity report at:  
www.FiveStarEquities.com/MDCO

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) shares soared 103.43 percent to close at $4.74 a share Wednesday. The stock traded between $4.65 and $7.21 on volume 17.91 million shares traded. The company announced that it has received a new 510(k) clearance from the FDA for the company's new Microcyn Scar Management HydroGel. Shares of Oculus Innovative Sciences have gained approximately 11.0 percent year-to-date.

Get more information on Oculus Innovative Sciences and free access to the in-depth equity report at:  
www.FiveStarEquities.com/OCLS

Walgreen Company (NYSE: WAG) shares declined 1.94 percent to close at $57.57 a share Wednesday. The stock traded between $57.30 and $58.61 on volume of 7.92 million shares traded. The company’s November sales were $6.07 billion, an increase of 4.1 percent when compared to a year ago. Shares of Walgreens have gained approximately 55.0 percent year-to-date.

Get more information on Walgreens and free access to the in-depth equity report at:  
www.FiveStarEquities.com/WAG

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:     
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *